Cosmo Pharmaceuticals
C43.F
#5638
Rank
A$1.42 B
Marketcap
$88.81
Share price
-2.91%
Change (1 day)
-25.29%
Change (1 year)

Revenue for Cosmo Pharmaceuticals (C43.F)

Revenue in 2024: A$0.43 Billion

According to Cosmo Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$0.43 Billion. In 2024 the company made a revenue of A$0.43 Billion an increase over the revenue in the year 2023 that were of A$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cosmo Pharmaceuticals from 2004 to 2024

Annual revenue

Year Revenue Change
2024A$0.43 B170.68%
2023A$0.15 B-6.34%
2022A$0.17 B48.59%
2021A$0.11 B-1.69%
2020A$0.11 B7.08%
2019A$0.10 B-6.74%
2018A$0.11 B-6.96%
2017A$0.12 B13.36%
2016A$0.11 B7.4%
2015A$0.10 B-31.54%
2014A$0.15 B24.35%
2013A$0.12 B-1.15%
2012A$0.12 B80.97%
2011A$67.76 M2.08%
2010A$66.38 M11.51%
2009A$59.53 M-19.97%
2008A$74.39 M49.4%
2007A$49.79 M59.87%
2006A$31.14 M8.89%
2005A$28.6 M22.77%
2004A$23.29 M